Skip to main content
Implanet SA logo

Implanet SA — Investor Relations & Filings

Ticker · ALIMP ISIN · FR0013470168 LEI · 969500CIMHFWNM4J4V14 PA Manufacturing
Open in API
Filings indexed 266 across all filing types
Latest filing 2024-01-03 Regulatory Filings
Country FR France
Listing PA ALIMP

About Implanet SA

http://www.implanet.com/en

Implanet is a medical technology company that designs, manufactures, and markets a range of implants and instruments for orthopedic surgery, with a specialized focus on spinal applications. The company's core offering is centered around its flagship Jazz™ platform, a latest-generation hybrid posterior fixation system intended to improve the treatment of various spinal disorders, including scoliosis. The product portfolio also includes other spinal systems such as Zeus™ and Saxxo™, Swingo™ interbody cages, Origin™ anterior cervical plates, and the Olea™ system for ultrasonic osteotomy. Additionally, Implanet provides complementary solutions like Neobone™ bone grafts. The company's products are utilized by surgeons and healthcare professionals in the field of spinal surgery.

Recent filings

Filing Released Lang Actions
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 100% confidence The document is a short press release dated January 3, 2024, announcing two main items: 1) The appointment of a new Listing Sponsor (Atout Capital) effective January 1, 2024. 2) The date for the next financial release (Annual Revenue 2023 on January 15, 2024). Since the document is short (2410 chars) and primarily serves to announce corporate actions and future reporting dates rather than being the full report itself, it fits the description of a general regulatory announcement or a specific corporate action announcement. The announcement of a new Listing Sponsor is a significant corporate event. While it could potentially be RNS (Regulatory Filings) as a fallback, the content is a specific corporate update that doesn't fit perfectly into the other specific categories like DIV, DIRS, or ER. However, given the nature of announcing a new Listing Sponsor and the upcoming earnings date, it is best classified as a general Regulatory Filing (RNS) or potentially a Report Publication Announcement (RPA) if it were announcing the publication of a report, which it is not doing for the 2023 revenue yet. Since it is a specific corporate update that doesn't match other codes, RNS is the most appropriate general category for miscellaneous regulatory news.
2024-01-03 French
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 95% confidence The document is a press release dated December 12, 2023, announcing the launch of a training program for Chinese surgeons in preparation for the commercialization of the JAZZ® range in China. It details operational updates (training, regulatory registration status) and includes quotes from management and a surgeon. It also announces the date for the next financial communication ('Chiffre d'affaires annuel 2023', January 15, 2024). This type of announcement, focusing on strategic operational progress and future reporting dates, is characteristic of a general corporate update or press release that doesn't fit the specific financial report categories (10-K, IR, ER). Since it is a general announcement about company activity and strategy, and not a formal regulatory filing like a 10-K or a specific financial result release (ER), it best fits the general Regulatory Filings (RNS) category as a catch-all for important, non-standard announcements, or potentially an Investor Presentation (IP) if it were structured as slides, but given the format, RNS is more appropriate as a general corporate news release.
2023-12-12 French
Inside Information / Other news releases
Regulatory Filings Classification · 100% confidence The document is a press release announcing operational news (launch of a training program in China) and includes a forward-looking statement about an upcoming financial publication ('2023 annual revenue, on January 15, 2024'). It is not a full financial report (like 10-K or IR), nor is it a transcript (CT) or a formal regulatory filing detailing specific transactions or results. Since it is a general announcement about business operations and future reporting schedules, it best fits the category of a general Regulatory Filing (RNS) or potentially an Earnings Release (ER) if it contained preliminary results, but it focuses on operational milestones. Given the content is primarily a business update and not a formal financial result announcement, RNS (Regulatory Filings/General Announcement) is the most appropriate fallback, although it shares characteristics with an ER announcement. However, since it explicitly announces the date of the *annual revenue* release, it functions as a general corporate update/announcement.
2023-12-12 English
Informations privilégiées / Autres communiqués
Share Issue/Capital Change Classification · 99% confidence The document is a press release dated December 11, 2023, announcing two key financial events: 1) The validation by Sanyou Medical's board to subscribe €5M to IMPLANET's upcoming capital increase, and 2) The drawing down of the remaining balance of a bond previously contracted. The text explicitly mentions the planned capital increase ('augmentation de capital') and the associated subscription commitment. This directly relates to fundraising and capital structure changes. The most appropriate category is 'Capital/Financing Update' (CAP). It is not a full 10-K, an earnings release (ER), or a proxy statement (DEF 14A/PSI). Since it is a detailed announcement about a financing event, it is classified as CAP rather than the general fallback (RNS).
2023-12-11 French
Inside Information / Other news releases
Share Issue/Capital Change Classification · 99% confidence The document is a press release dated December 11, 2023, announcing a commitment from Sanyou Medical to subscribe to IMPLANET's planned capital increase and the drawdown of a bond issue tranche. This content directly relates to financing activities, capital structure changes, and fundraising efforts. This aligns perfectly with the definition of 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a formal proxy statement (DEF 14A/PSI). It is a specific announcement about capital raising, making CAP the most appropriate classification.
2023-12-11 English
Inside Information / Other news releases
Share Issue/Capital Change Classification · 99% confidence The document is explicitly titled as a 'Press release' and details the outcome of an 'Extraordinary General Meeting' (EGM) where shareholders approved a planned capital increase. While the content relates to capital structure changes (CAP) and shareholder voting (DVA), the primary purpose of this specific document is to announce the results of the shareholder vote regarding the capital increase authorization. Since the text focuses on the adoption of resolutions at the EGM concerning a capital increase, it strongly aligns with an announcement related to capital structure changes and shareholder decisions. However, the core event being reported is the shareholder approval of a capital increase, which falls under 'Capital/Financing Update' (CAP) or potentially 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Given the emphasis on the authorization for the capital increase, CAP is highly relevant. Since the document is a press release announcing the outcome of a shareholder vote on a financing action, and there is no specific code for 'EGM Results on Financing', I must choose the best fit. The approval of the capital increase is the key outcome, making CAP a strong candidate. Alternatively, DVA covers official results from shareholder votes. Since the document explicitly states 'IMPLANET receives the approval of its shareholders for its planned capital increase' and details the voting outcome, DVA is the most precise fit for reporting the voting results of a general meeting, even if the subject matter is capital raising. I will select DVA as it directly addresses the reporting of voting results from a general meeting.
2023-11-16 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.